Junka, A.; Brożyna, M.; Krzyżek, P.; Tomczyk, M.; Krasucki, K.; Matys, T.; Musiała, T.; Stafiniak, M.; Fal, A.
Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota. Int. J. Mol. Sci. 2025, 26, 10045.
https://doi.org/10.3390/ijms262010045
AMA Style
Junka A, Brożyna M, Krzyżek P, Tomczyk M, Krasucki K, Matys T, Musiała T, Stafiniak M, Fal A.
Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota. International Journal of Molecular Sciences. 2025; 26(20):10045.
https://doi.org/10.3390/ijms262010045
Chicago/Turabian Style
Junka, Adam, Malwina Brożyna, Paweł Krzyżek, Michał Tomczyk, Krzysztof Krasucki, Tomasz Matys, Tomasz Musiała, Marta Stafiniak, and Andrzej Fal.
2025. "Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota" International Journal of Molecular Sciences 26, no. 20: 10045.
https://doi.org/10.3390/ijms262010045
APA Style
Junka, A., Brożyna, M., Krzyżek, P., Tomczyk, M., Krasucki, K., Matys, T., Musiała, T., Stafiniak, M., & Fal, A.
(2025). Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota. International Journal of Molecular Sciences, 26(20), 10045.
https://doi.org/10.3390/ijms262010045